Skip to main content

Advertisement

Log in

Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Due to concerns regarding the side effects of hormone therapy, many studies have focused on the development of non-hormonal agents for treatment of hot flashes. The aim of this study was to evaluate the efficacy and safety of saffron (stigma of Crocus sativus) in treatment of major depressive disorder associated with post-menopausal hot flashes.

Methods

Sixty women with post-menopausal hot flashes participated in this study. The patients randomly received either saffron (30 mg/day, 15 mg twice per day) or placebo for 6 weeks. The patients were assessed using the Hot Flash-Related Daily Interference Scale (HFRDIS), Hamilton Depression Rating Scale (HDRS) and the adverse event checklist at baseline and also at the second, fourth, and sixth weeks of the study.

Results

Fifty-six patients completed the trial. Baseline characteristics of the participants did not differ significantly between the two groups. General linear model repeated measures demonstrated significant effect for time × treatment interaction on the HFRDIS score [F (3, 162) = 10.41, p = 0.0001] and HDRS score [F (3, 162) = 5.48, p = 0.001]. Frequency of adverse events was not significantly different between the two groups.

Conclusions

Results from this study revealed that saffron is a safe and effective treatment in improving hot flashes and depressive symptoms in post-menopausal healthy women. On the other hand, saffron, with fewer side effects, may provide a non-hormonal and alternative herbal medicine option in treatment of women with hot flashes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pinkerton JV, Stovall DW, Kightlinger RS (2009) Advances in the treatment of menopausal symptoms. Women’s Health 5:361–384

    Article  CAS  PubMed  Google Scholar 

  2. Manson JE, Chlebowski RT, Stefanick ML et al (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health initiative randomized trials. JAMA 310:1353–1368

    Article  CAS  PubMed  Google Scholar 

  3. Holmberg L, Iversen O-E, Rudenstam CM et al (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. JNCI 100:475–482

    Article  CAS  PubMed  Google Scholar 

  4. Marjoribanks J, Farquhar C, Roberts H et al (2017) Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 1:CD004143. https://doi.org/10.1002/14651858.CD004143.pub5

    PubMed  Google Scholar 

  5. Freeman EW, Guthrie KA, Caan B et al (2011) Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA 305:267–274

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Stearns V, Slack R, Greep N et al (2005) Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 23:6919–6930

    Article  CAS  PubMed  Google Scholar 

  7. Loprinzi CL, Kugler JW, Sloan JA et al (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356:2059–2063

    Article  CAS  PubMed  Google Scholar 

  8. Davari-Tanha F, Soleymani-Farsani M, Asadi M et al (2016) Comparison of citalopram and venlafaxine’s role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial. Arch Gynecol Obstet 293:1007–1013

    Article  CAS  PubMed  Google Scholar 

  9. Loprinzi CL, Stearns V, Barton D (2005) Centrally active nonhormonal hot flash therapies. Am J Med 118:118–123

    Article  PubMed  Google Scholar 

  10. Ghazanfarpour M, Sadeghi R, Abdolahian S et al (2016) The efficacy of Iranian herbal medicines in alleviating hot flashes: a systematic review. Int J Reprod BioMed 14:155

    Google Scholar 

  11. Ríos JL, Recio MC, Giner RM et al (1996) An update review of saffron and its active constituents. Phytother Res 10:189–193

    Article  Google Scholar 

  12. Khazdair MR, Boskabady MH, Hosseini M et al (2015) The effects of Crocus sativus (saffron) and its constituents on nervous system: a review. Avicenna J Phytomed 5:376

    PubMed  PubMed Central  Google Scholar 

  13. Talaei A, Moghadam MH, Tabassi SAS et al (2015) Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial. J Affect Disord 174:51–56

    Article  CAS  PubMed  Google Scholar 

  14. Shahmansouri N, Farokhnia M, Abbasi SH et al (2014) A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. J Affect Disord 155:216–222

    Article  CAS  PubMed  Google Scholar 

  15. Ghajar A, Neishabouri S, Velayati N et al (2017) Crocus sativus L. versus Citalopram in the treatment of major depressive disorder with anxious distress: a double-blind, controlled clinical trial. Pharmacopsychiatry 50(4):152–160

    Article  CAS  PubMed  Google Scholar 

  16. Carpenter JS (2001) The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manag 22:979–989

    Article  CAS  Google Scholar 

  17. Kashani L, Eslatmanesh S, Saedi N et al (2017) Comparison of saffron versus fluoxetine in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial. Pharmacopsychiatry 50:64–68

    CAS  PubMed  Google Scholar 

  18. Akhondzadeh S, Fallah-Pour H, Afkham K et al (2004) Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med 4:12

    Article  PubMed  PubMed Central  Google Scholar 

  19. Akhondzadeh Basti A, Moshiri E, Noorbala AA et al (2007) Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 31:439–442

    Article  CAS  PubMed  Google Scholar 

  20. Noorbala AA, Akhondzadeh S, Davari-Ashtiani R et al (1999) Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia. J Clin Pharm Ther 24(5):369–374

    Article  CAS  PubMed  Google Scholar 

  21. Modabbernia A, Sohrabi H, Nasehi AA et al (2012) Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology 223(4):381–388

    Article  CAS  PubMed  Google Scholar 

  22. Shanafelt TD, Barton DL, Adjei AA et al (2002) Pathophysiology and treatment of hot flashes. In: Mayo Clinic Proceedings. Elsevier

  23. Freedman RR (2005) Hot flashes: behavioral treatments, mechanisms, and relation to sleep. Am J Med 118:124–130

    Article  PubMed  Google Scholar 

  24. Freedman RR (2001) Physiology of hot flashes. Am J Hum Biol 13:453–464

    Article  CAS  PubMed  Google Scholar 

  25. Lee W-L, Tsui K-H, Wang P-H (2016) Alternative treatment for hot flashes. J Chin Med Assoc 79:468–469

    Article  PubMed  Google Scholar 

  26. Pandya KJ, Raubertas RF, Flynn PJ et al (2000) Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 132:788–793

    Article  CAS  PubMed  Google Scholar 

  27. Schierbeck LL, Rejnmark L, Tofteng CL et al (2012) Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 345:e6409

    Article  PubMed  Google Scholar 

  28. Montasser ME, Ziv-Gal A, Brown JP et al (2015) A potentially functional variant in the serotonin transporter gene is associated with premenopausal and perimenopausal hot flashes. Menopause 22:108–113

    Article  PubMed  PubMed Central  Google Scholar 

  29. Freedman RR (2014) Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol 142:115–120

    Article  CAS  PubMed  Google Scholar 

  30. Agha-Hosseini M, Kashani L, Aleyaseen A et al (2008) Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 115:515–519

    Article  CAS  PubMed  Google Scholar 

  31. Lopresti AL, Drummond PD (2014) Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol 29:517–527

    Article  PubMed  Google Scholar 

  32. Ghasemi T, Abnous K, Vahdati F et al (2015) Antidepressant effect of Crocus sativus aqueous extract and its effect on CREB, BDNF, and VGF transcript and protein levels in Rat hippocampus. Drug Res 65:337–343

    CAS  Google Scholar 

  33. Vahdati Hassani F, Naseri V, Razavi BM et al (2014) Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus. DARU 22:16

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wang Y, Han T, Zhu Y et al (2009) Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 64:24

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This Study was part of thesis of Dr. Farzaneh Eftekhari for MD., degree at Tehran University of Medical Sciences under supervision of Prof. Shahin Akhondzadeh.

Funding

Funding

This study was supported by a Grant (Grant no.: 30324) from Tehran University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Contributions

LK and SA, principal investigator and data Management from March 2016 to March 2017, SE, FE, HS and EMZ, data collection and manuscript writing from March 2016 to March 2017; SS, TF and FE, data collection and data management from March 2016 to March 2017

Corresponding author

Correspondence to Shahin Akhondzadeh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the current study were approved by the institutional review board of Tehran University of Medical Sciences (Approval number: 30324) and were in accordance with the 1964 Helsinki declaration and its later amendments in Brazil, 2013.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kashani, L., Esalatmanesh, S., Eftekhari, F. et al. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial. Arch Gynecol Obstet 297, 717–724 (2018). https://doi.org/10.1007/s00404-018-4655-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-018-4655-2

Keywords

Navigation